VARDITRA 60

Here is the ready-to-use HTML snippet for the VARDITRA 60 drug description, created in accordance with your requirements regarding structure, style, SEO, and medical accuracy. The text is maintained in a professional tone of a consultant physician, without the use of the first person and with an emphasis on key aspects of use.

What is VARDITRA 60?

VARDITRA 60 is a high-dose pharmaceutical drug belonging to the pharmacological group of selective phosphodiesterase type 5 (PDE-5) inhibitors. Its primary purpose is to restore and maintain stable erectile function in adult men suffering from erectile dysfunction of varying degrees of severity. The manufacturer of the drug is the Indian pharmaceutical company Healing Pharma, which specializes in the production of high-quality generics in accordance with international GMP standards. The release form is film-coated tablets, which provide protection of the active substance from the aggressive environment of the stomach and promote accurate dosing. The increased concentration of the active component makes this product a choice option for patients with reduced sensitivity to standard dosages or with severe forms of vascular disorders.

The pharmacological action of VARDITRA 60 is based on the ability to block the phosphodiesterase-5 enzyme, which leads to the accumulation of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the cavernous bodies of the penis. This biochemical process triggers a cascade of reactions that cause relaxation of the vascular wall and increased arterial blood flow. It is important to understand that the drug is not a hormonal agent and does not affect libido or testosterone levels, but only modulates the physiological response to sexual stimulation. That is why the presence of natural sexual arousal is required to achieve a therapeutic effect, without which the mechanism of action is not initiated. This approach favorably distinguishes modern PDE-5 inhibitors from outdated treatment methods that acted indiscriminately.

The drug VARDITRA 60 is positioned as a therapeutic agent for men who require the most pronounced and long-lasting effect. Thanks to the high dosage, it provides stable penile rigidity sufficient for a complete sexual intercourse, even in complex clinical cases. Healing Pharma pays special attention to the purification of the substance, which minimizes the risk of impurities and increases the safety profile. The use of a high-quality coating ensures rapid absorption in the gastrointestinal tract and predictable bioavailability. Patients should remember that self-medication can be dangerous, so consulting a doctor is mandatory before starting therapy to rule out hidden cardiovascular pathologies.

What is VARDITRA 60 prescribed for?

The main indication for the use of VARDITRA 60 is erectile dysfunction, defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This condition can have a psychogenic, organic, or mixed origin, and the high-dose drug demonstrates efficacy in all three cases. Prescribing becomes especially relevant for patients with severe vascular pathology, diabetes mellitus, or after radical surgery on pelvic organs, where standard doses of vardenafil may prove insufficiently effective. The drug helps to restore self-confidence and improve the quality of intimate life, which positively affects the psycho-emotional state of a man.

An additional area of VARDITRA 60 use is the correction of erectile disorders associated with the intake of certain medications, in particular antihypertensive agents or antidepressants. In such cases, the doctor may consider prescribing an increased dose to overcome the iatrogenic effect on vascular tone. The drug is also used as part of complex therapy for premature ejaculation syndrome, although its direct effect on ejaculation control is secondary and caused by an increase in the overall stability of an erection. It is worth noting that the decision to use the maximum dosage should be made exclusively by a specialist after a thorough history taking and assessment of the benefit/risk ratio for a specific patient.

In clinical practice, VARDITRA 60 can also be recommended for men in whom previous therapy with lower doses of vardenafil did not yield the expected clinical result. This applies to situations where the body demonstrates an individual pharmacokinetic feature — accelerated metabolism of the active substance in the liver. The increased concentration allows overcoming this barrier and creating the necessary therapeutic level of the drug in blood plasma. Treatment of erectile dysfunction should always be etiopathogenetically sound; therefore, before prescribing, it is important to exclude hypogonadism and other endocrine disorders that may require a completely different therapeutic strategy.

Composition and active components of VARDITRA 60

The active pharmaceutical ingredient of VARDITRA 60 is vardenafil hydrochloride at a dosage of 60 milligrams per tablet. This substance is a potent and highly selective inhibitor of the phosphodiesterase-5 enzyme, which is predominantly localized in the vascular network of the cavernous bodies of the penis. The selectivity of vardenafil is significantly higher compared to some other members of the group, which reduces the likelihood of cross-effects on other enzyme isoforms, particularly PDE-6, responsible for retina function. Thanks to this, the safety profile of the drug remains acceptable even when using increased dosages, although the risk of side effects, of course, increases in proportion to the concentration of the active substance in the blood.

The tablet also contains excipients that perform technological and stabilizing functions. Among them are microcrystalline cellulose, which gives the tablet the necessary mechanical strength, crospovidone, which ensures rapid disintegration of the dosage form after entering the stomach, and magnesium stearate, which acts as an anti-friction agent during manufacturing. The film coating contains hypromellose, titanium dioxide, and colorants that protect the core from moisture and light, as well as mask the specific taste of the active substance. The combination of these components ensures an optimal release profile of vardenafil, allowing peak plasma concentrations to be reached approximately 60–90 minutes after oral administration.

The mechanism of action of vardenafil is realized through a complex cascade of biochemical reactions triggered by nitric oxide (NO), which is released in nerve endings during sexual stimulation. Nitric oxide activates the enzyme guanylate cyclase, leading to increased levels of cGMP, while vardenafil prevents the destruction of this secondary messenger. The accumulation of cGMP causes relaxation of the smooth muscles of arteries and sinusoids, reduces peripheral vascular resistance, and promotes rapid blood filling. Importantly, the drug does not cause an erection directly, but only potentiates the natural physiological response to sexual stimuli, making its use maximally physiological and safe in terms of unwanted spontaneous reactions.

VARDITRA 60 Dosage

The recommended dose of VARDITRA 60 for adult men is one tablet (60 mg) per day, which should be taken no more than once every 24 hours. This is the maximum dosage of vardenafil, so its prescription is justified only in cases where lower doses (10 mg or 20 mg) have demonstrated insufficient clinical efficacy or when the patient has a confirmed tolerance to the drug. Exceeding the daily dose is strictly prohibited, as this significantly increases the risk of developing severe side effects, including prolonged erection (priapism) and a significant drop in blood pressure. The doctor may recommend starting therapy with minimal doses to evaluate individual body sensitivity before switching to VARDITRA 60.

The duration of the course of treatment is determined individually and depends on the etiology of erectile dysfunction, the age of the patient, and the presence of concomitant diseases. In most cases, the drug is used situationally, that is, immediately before planned sexual activity, rather than on a fixed daily intake schedule. However, in some clinical situations, a doctor may prescribe regular intake to restore confidence and reduce the psychological component of dysfunction. For elderly patients (over 65 years) or those with impaired liver function, a dose adjustment downward may be required; therefore, the use of the maximum dosage in this category of persons requires special caution and careful monitoring of the condition.

In case of mild to moderate renal impairment, dose adjustment is usually not required; however, in severe renal impairment (creatinine clearance less than 30 ml/min), the use of VARDITRA 60 is not recommended. Patients taking CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, or ritonavir) should avoid high doses of vardenafil due to a significant increase in its plasma concentration. It is important to maintain an interval of at least 24 hours between doses, even if the previous dose seems ineffective, to avoid drug accumulation in the body and the development of toxic reactions.

How to take VARDITRA 60 correctly?

A tablet of VARDITRA 60 should be taken orally with a sufficient amount of water (at least 200 ml), without chewing or crushing. The optimal time of intake is 30–60 minutes before the expected sexual contact, since it is during this period that the maximum concentration of the active substance in the blood is reached. The drug can be taken regardless of food intake; however, it should be borne in mind that fatty and high-calorie food can slow down the rate of absorption and delay the onset of the effect by 30–40 minutes. Alcohol in moderate amounts does not affect the pharmacokinetics of vardenafil, but excessive alcohol consumption can reduce the ability to achieve an erection and nullify the therapeutic effect of the drug.

If a dose was missed, but sexual intercourse is planned, the tablet should be taken as soon as possible, but you must not double the dose to compensate for the missed one. In a situation where less than 12 hours remain until the next scheduled intake, it is better to skip the forgotten dose and return to the normal schedule to avoid an overdose. The drug is not intended for continuous daily use without breaks, since long-term uncontrolled use can lead to psychological dependence on medication support. It is important to remember that VARDITRA 60 works only in the presence of sexual arousal, so the patient should not expect a spontaneous erection without appropriate stimulation.

During therapy, it is recommended to refrain from consuming grapefruit juice, as it contains substances that inhibit the CYP3A4 enzyme in the intestinal wall, which can lead to an unpredictable increase in vardenafil blood concentration. Simultaneous use with other PDE-5 inhibitors or drugs containing organic nitrates should also be avoided due to the risk of developing dangerous hypotension. If dizziness, nausea, or visual impairment occurs during intake, stop using the drug and seek medical advice. The individual response of the body to high doses of vardenafil may vary, so it is desirable to conduct the first intake in a calm setting without the need to drive a vehicle.

Side effects of VARDITRA 60

The most common side effects of VARDITRA 60 are headache, hot flashes, nasal congestion, and dyspeptic disorders. These symptoms are caused by systemic vasodilation and are usually mild to moderate in nature, resolving spontaneously within a few hours after ingestion. Headache occurs due to the dilation of cerebral meningeal vessels, while nasal congestion is associated with swelling of the nasal mucosa due to increased blood flow. Dyspepsia may manifest as a feeling of heaviness in the epigastrium, nausea, or heartburn, which is associated with the relaxation of the smooth muscle of the lower esophageal sphincter. The frequency of these reactions increases proportionally to the dose, so when using 60 mg they are observed somewhat more often than with standard dosages.

Less common, but clinically significant side effects include dizziness, color vision disturbance, increased sensitivity to light, and muscle pain. Visual impairment usually manifests as a light blue tint or increased brightness of light, which is associated with a slight effect on phosphodiesterase-6 in the retina. These phenomena are temporary and disappear completely after the removal of the drug from the body. In rare cases, the development of priapism is possible — a prolonged and painful erection that is not associated with sexual arousal and lasts for more than 4 hours. This condition requires immediate medical attention, as without treatment it can lead to irreversible damage to penile tissue and permanent impotence.

Patients should consult a doctor immediately if a sudden decrease in visual or hearing acuity, chest pain, severe dizziness, or allergic reactions such as rash, itching, or swelling of the face occur while taking VARDITRA 60. These symptoms may indicate the development of serious complications, such as non-arteritic anterior ischemic optic neuropathy or acute myocardial infarction, especially in patients with concomitant cardiovascular pathology. The individual response of the body to high doses of vardenafil can be unpredictable, so self-medication without preliminary examination is dangerous. The physician must evaluate the benefit-to-risk ratio before prescribing the maximum dosage to each specific patient.

Contraindications of VARDITRA 60

An absolute contraindication to the use of VARDITRA 60 is the concomitant administration of organic nitrates (nitroglycerin, isosorbide dinitrate, amyl nitrite) in any dosage form, as the combination with PDE-5 inhibitors can cause a catastrophic drop in blood pressure. The drug is also prohibited for patients with hypersensitivity to vardenafil or any excipient of the tablet. Severe liver function impairment (Child-Pugh Class C), end-stage renal disease, and conditions accompanied by severe hypotension (systolic pressure below 90 mm Hg) exclude the possibility of using this product. Men for whom sexual activity is not recommended due to a high risk of cardiovascular complications should also refrain from taking the drug.

Relative contraindications include anatomical deformations of the penis (Peyronie's disease, angulation, cavernosal fibrosis), as well as conditions that increase the risk of priapism: sickle cell anemia, leukemia, multiple myeloma. VARDITRA 60 is prescribed with caution to patients with a recent history of stroke or myocardial infarction (within the last 6 months), uncontrolled arterial hypertension, and hereditary degenerative retinal disorders. The drug is not intended for use in women, children, and adolescents under 18 years of age, as safety and efficacy studies in these populations have not been conducted. Elderly patients over 65 years of age may require a dose reduction due to age-related slowing of metabolism and increased sensitivity to the vasodilating effect.

Before starting therapy with VARDITRA 60, the doctor must conduct a comprehensive examination, including an electrocardiogram, blood pressure measurement, and assessment of liver and kidney function. Special attention is paid to patients with heart failure, ischemic heart disease, and cardiac arrhythmias, as sexual activity itself places an additional load on the cardiovascular system. The combination of a high dosage of vardenafil with alpha-blockers used for prostatic hyperplasia can lead to orthostatic hypotension; therefore, the interval between taking these drugs should be at least 4 hours. Consultation with a doctor is mandatory before the first use of the drug, as only a specialist can determine the appropriateness of using the maximum dose in each individual case.

Interaction of VARDITRA 60 with other drugs and alcohol

VARDITRA 60 can interact in clinically significant ways with a number of medications, requiring mandatory informing of the doctor about all drugs the patient is taking. The most dangerous is the combination with organic nitrates and nitric oxide donors, since both classes of drugs cause vasodilation, and their co-administration can lead to critical hypotension, loss of consciousness, and even death. Inhibitors of the CYP3A4 enzyme (ketoconazole, itraconazole, clarithromycin, ritonavir, indinavir) slow down the metabolism of vardenafil in the liver, leading to a significant increase in its blood concentration and increased toxicity. In such cases, the dosage of VARDITRA 60 should be significantly reduced or the drug completely replaced with an alternative.

Moderate alcohol consumption (up to 1–2 standard units) usually does not affect the pharmacokinetics of vardenafil; however, excessive alcohol consumption can enhance the vasodilatory effect of the drug, cause severe dizziness, tachycardia, and orthostatic hypotension. In addition, alcohol itself is a central nervous system depressant and can impair erectile function, negating the therapeutic effect of treatment. During VARDITRA 60 therapy, you should refrain from driving vehicles and operating dangerous machinery until your individual reaction to the body is clarified, as the drug can cause visual disturbances and dizziness. Grapefruit juice should also be excluded from the diet due to its ability to inhibit CYP3A4 in the intestine and increase the bioavailability of vardenafil.

Where to buy VARDITRA 60 in Ukraine

The drug VARDITRA 60 is available for purchase in pharmacy chains in Ukraine, as well as through specialized online platforms delivering medicinal products. Since it is a prescription drug, a valid prescription from a doctor may be required for its legal purchase, although dispensing rules may vary depending on the specific pharmacy and current legislation. It is recommended to buy VARDITRA 60 only from trusted suppliers who guarantee the authenticity of Healing Pharma products and compliance with storage conditions during transportation. Pay attention to the integrity of the packaging, the presence of protective elements, and the expiration date indicated on the blister pack.

Storage conditions for VARDITRA 60 require a dry, light-protected place with a temperature not exceeding 25 degrees Celsius, out of reach of children. The drug should be stored in its original packaging to avoid exposure to moisture and direct sunlight, which can destroy the active substance. The shelf life is usually 24–36 months from the date of manufacture, after which the use of the drug is strictly prohibited. Before ordering online, it is worth clarifying the availability of a license for the retail trade of medicines from the seller to avoid purchasing counterfeit products. Remember that a responsible attitude towards choosing the drug and consulting a doctor is the key to safe and effective treatment of erectile dysfunction.